Malaria

Development Of New Drugs Urged As Chloroquine Resistance Grows In Africa

Published in TB and Outbreaks Week, April 17th, 2001

by N.R. Saltmarsh, staff medical writer - Resistance of Plasmodium falciparum to chloroquine has rendered the drug next to useless in some areas of sub-Saharan Africa, and may even be responsible for emerging epidemics and mortality.

The limited supply of alternative anti-malarials highlights a need for development of more effective and plentiful drugs in African nations, said Fred Nuwaha at Mbarara University in Uganda.

"There is emerging evidence that chloroquine-resistant P. falciparum (CRPF) is linked with increased incidence of mortality, severe disease and emergence of epidemics," Nuwaha said. "Whereas the normal response to this...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-04-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry